Synonyms:
Status: Phase 3
Entry Type: Gene
Molecule Category: UKNOWN
UNII: 7K2YOJ14X0

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT B-lymphocyte antigen CD19 binding agent FDA PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Non-Hodgkin 3 D008228 ClinicalTrials
Lymphoma, Large B-Cell, Diffuse 2 D016403 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 D054198 ClinicalTrials
Lymphoma, Mantle-Cell 1 D020522 ClinicalTrials
Lymphoma, Follicular 1 D008224 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297236
FDA SRS 7K2YOJ14X0